| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/27/2006 | CA2827654A1 Method for generating an animal homozygous for a genetic modification |
| 04/27/2006 | CA2584984A1 Methods for assembly of high fidelity synthetic polynucleotides |
| 04/27/2006 | CA2584921A1 Neuron regeneration |
| 04/27/2006 | CA2584753A1 Method for controlling insects of the order diptera using a bacillus thuringiensis strain |
| 04/27/2006 | CA2584661A1 Increased wax production in plants |
| 04/27/2006 | CA2584639A1 Adenovirus fiber shaft composition and methods of use |
| 04/27/2006 | CA2584633A1 Vehicle to transport a dna-modifying enzyme to a genome |
| 04/27/2006 | CA2584625A1 Ami-deficient streptococcus thermophilus strains with reduced post-acidification |
| 04/27/2006 | CA2584518A1 Device and method for removing heavy metals from contaminated samples with membranes comprising purified metallothionein |
| 04/27/2006 | CA2584512A1 Truncated fragments of alpha-synuclein in lewy body disease |
| 04/27/2006 | CA2584511A1 Phytase from buttiauxella sp. |
| 04/27/2006 | CA2584459A1 Modulation of neuroglia-derived bdnf in the treatment and prevention of pain |
| 04/27/2006 | CA2584116A1 Neurotransmitter sensors and methods of using the same |
| 04/27/2006 | CA2584108A1 Development of sensitive fret sensors and methods of using the same |
| 04/27/2006 | CA2584048A1 Multi-domain amphipathic helical peptides and methods of their use |
| 04/27/2006 | CA2584004A1 Pufa polyketide synthase systems and uses thereof |
| 04/27/2006 | CA2583937A1 Chimeric protein |
| 04/27/2006 | CA2583860A1 Vehicle for the transport of a chosen molecule to a cell |
| 04/27/2006 | CA2583762A1 Polypeptide having a phytase activity and nucleotide sequence coding therefor |
| 04/27/2006 | CA2583750A1 Methods for generating a rodent having a genetic modification |
| 04/27/2006 | CA2583690A1 Microrna constructs for the suppression of the expression of targeted genes or the down regulation of targeted genes and methods therefore |
| 04/27/2006 | CA2583576A1 Chimera (double) decoy |
| 04/27/2006 | CA2582686A1 Method of producing uridine 5'-diphospho-n-acetylgalactosamine |
| 04/27/2006 | CA2582304A1 Scarecrow-like stress-related polypeptides and methods of use in plants |
| 04/27/2006 | CA2581099A1 Enzymes involved in triterpene synthesis |
| 04/27/2006 | CA2576643A1 Screening assays for inhibitors of a staphylococcus aureus siderophore |
| 04/26/2006 | EP1650313A1 Method and probe set for detecting cancer |
| 04/26/2006 | EP1650312A2 Functional assay of high-density lipoprotein |
| 04/26/2006 | EP1650310A1 Recombinant avian adenovirus vector |
| 04/26/2006 | EP1650309A1 Lentiviral vectors for the preparation of immunotherapeutical compositions |
| 04/26/2006 | EP1650308A1 Nucleic acid sequences encoding proteins capable of associating into a virus-like particle |
| 04/26/2006 | EP1650307A2 Methods for making recombinant proteins using apoptosis inhibitors |
| 04/26/2006 | EP1650306A2 Means and methods for modifying gene expression using unpolyadenylated RNA |
| 04/26/2006 | EP1650305A1 Mutants of the factor VII activating protease and methods for their detection |
| 04/26/2006 | EP1650304A2 Cloning and recombinant production of vespid venom phospholipase and immunological therapies based thereon |
| 04/26/2006 | EP1650303A2 Method for generating a substracted cDNA library and uses of the generated library |
| 04/26/2006 | EP1650302A1 Protein capable of deposition onto extracellular matrix |
| 04/26/2006 | EP1650301A1 Gene imparting redifferentiation ability of plant and utilization of the same |
| 04/26/2006 | EP1650300A1 Method of judging risk for onset of drug-induced granulocytopenia |
| 04/26/2006 | EP1650299A1 Method of detecting reaction of dna and dna-binding protein |
| 04/26/2006 | EP1650298A1 Oligonucleotide generators based on U6-type RNA polymerase III promoters |
| 04/26/2006 | EP1650297A2 Method and apparatus for the rapid disruption of cells or viruses using micro magnetic beads and laser |
| 04/26/2006 | EP1650296A1 Variant serine acetyltransferase and process for producing l-cysteine |
| 04/26/2006 | EP1650294A1 Production of avian embryonic germ (EG) cell lines by prolonged culturing of PGCS, use thereof for cloning and chimerization |
| 04/26/2006 | EP1650225A1 Hetero type pentamer recombinant vaccine |
| 04/26/2006 | EP1650223A2 Rad51-brc repeat crystals |
| 04/26/2006 | EP1650221A2 Novel compounds |
| 04/26/2006 | EP1650220A2 Anti-VEGF antibodies |
| 04/26/2006 | EP1650219A1 Human toll homologues |
| 04/26/2006 | EP1649743A1 Method of direct regeneration, Shikonin induction in callus and Agrobacterium rhizogenes-mediated genetic transformation of Arnebia hispidissima |
| 04/26/2006 | EP1649403A2 Method for determining metabolic flux affecting substance production |
| 04/26/2006 | EP1649058A2 Use of silver gene for the authentication of the racial origin of animal populations, and of the derivative products thereof |
| 04/26/2006 | EP1649056A1 Methods for amplifying and detecting nucleic acids in microfluidic devices under continuous and non-continuous flow conditions. |
| 04/26/2006 | EP1649054A1 Method for diagnosing colorectal cancers |
| 04/26/2006 | EP1649047A1 Methods for detecting aneuploidy using microparticle multiplex detection |
| 04/26/2006 | EP1649041A2 Multimeric oxidoreductases |
| 04/26/2006 | EP1649030A2 Metabolically engineered bacterial strains having enhanced 2-keto-d-gluconate accumulation |
| 04/26/2006 | EP1649028A2 Adenoviral vector-based vaccines |
| 04/26/2006 | EP1649027A1 Expression systems for insect pest control |
| 04/26/2006 | EP1649026A2 Genotoxicity testing |
| 04/26/2006 | EP1649025A2 Methods of decoupling reaction scale and protein synthesis yield in batch mode |
| 04/26/2006 | EP1649024A2 Methods and means for regulating gene expression |
| 04/26/2006 | EP1649022A1 Wheat with altered branching enzyme activity and starch and starch containing products derived thereform |
| 04/26/2006 | EP1649021A1 Plant cell cycle genes and methods of use |
| 04/26/2006 | EP1649020A1 Synthetic gene encoding human epidermal growth factor 2/neu antigen and uses thereof |
| 04/26/2006 | EP1649019A2 Improved inhibitor nucleic acids |
| 04/26/2006 | EP1649018A2 Sp1 and sp3 targeted cancer therapies and therapeutics |
| 04/26/2006 | EP1649017A1 Use of rnai inhibiting parp activity for the manufacture of a medicament for the treatment of cancer |
| 04/26/2006 | EP1649016A1 Clean-up beads |
| 04/26/2006 | EP1649015A1 Nucleic acid isolation |
| 04/26/2006 | EP1649010A2 Novel nucleic acids from sesame plants |
| 04/26/2006 | EP1649006A2 Exo-specific amylase polypeptides, nucleic acids encoding those polypeptides and uses thereof |
| 04/26/2006 | EP1649005A2 P450 oxygenases and methods of use |
| 04/26/2006 | EP1649002A2 Rna processing protein complexes and uses thereof |
| 04/26/2006 | EP1648997A2 Methods of treatment and disgnosis using modulators of virus-induced cellular gene sequences |
| 04/26/2006 | EP1648996A2 Enzymes for starch processing |
| 04/26/2006 | EP1648939A2 Anti-vegf antibodies |
| 04/26/2006 | EP1648938A1 Bcl-2 splicing variants |
| 04/26/2006 | EP1648935A2 Antagonists and agonists of ldcam and methods of use |
| 04/26/2006 | EP1648931A2 Novel multifunctional cytokines |
| 04/26/2006 | EP1648929A2 Active subfragments of human histidine rich glycoprotein |
| 04/26/2006 | EP1648918A2 Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof |
| 04/26/2006 | EP1648914A2 Oligomeric compounds and compositions for use in modulation of small non-coding rnas |
| 04/26/2006 | EP1648910A2 Antisense modulation of stearoyl-coa desaturase expression |
| 04/26/2006 | EP1648909A2 Thioaptamers enable discovery of physiological pathways and new therapeutic strategies |
| 04/26/2006 | EP1648555A2 Apparatus for generating electrical pulses and methods of using the same |
| 04/26/2006 | EP1648520A1 Compounds and methods for downregulating the effects of tgf-beta |
| 04/26/2006 | EP1648519A2 Lipid encapsulated interfering rna |
| 04/26/2006 | EP1648511A1 Antibodies and methods for generating genetically altered antibodies with enhanced effector function |
| 04/26/2006 | EP1648503A2 Active or passive immunization against proapoptotic neurotrophins for the treatment or prevention of neurodegenerative deseases |
| 04/26/2006 | EP1648499A2 P. aeruginosa mucoid exopolysaccharide specific binding peptides |
| 04/26/2006 | EP1648487A2 Immunotherapeutics for biodefense |
| 04/26/2006 | EP1648481A1 Viral vectors |
| 04/26/2006 | EP1648474A2 Methods and pharmaceutical compositions for healing wounds |
| 04/26/2006 | EP1648388A2 Novel targets and compositions for use in decontamination, immunoprophylaxis, and post-exposure therapy against anthrax |
| 04/26/2006 | EP1648224A1 Rat model of diabetic nephropathy |
| 04/26/2006 | EP1648223A1 Npc1l1 (npc3) and methods of use thereof |
| 04/26/2006 | EP1581553A4 Enzymes and polynucleotides encoding the same |
| 04/26/2006 | EP1575977A4 Immunostimulatory sequence oligonucleotides and methods of using the same |
| 04/26/2006 | EP1571901A4 Generation of plants with altered oil content |